In silico screening of potential antiviral inhibitors against SARS-CoV-2 main protease

Respiratory illness due to SARS-CoV-2 emerged in 2019 and has a significant morbidity and mortality rate. The main protease (Mpro) is mainly responsible for viral replications, which acts as a good drug target to inhibit SARS-CoV-2-related diseases. Chemical compounds obtained from various herbal plants are showing potent antiviral activity against numerous viral diseases. Initial screening was performed with the phytochemicals against Mpro using molecular docking. This result shows that there is a strong interaction exhibited between active sites (His-41 and Cys-145) of Mpro with chemical compounds. In addition, ADME prediction and Lipinski's rule of five (RO5) calculations demonstrated that the selected compounds have potential drug-like properties. Further, molecular dynamics (MD) simulations were performed to understand the stability and structural changes of protein-ligand complexes for the top five compounds. MM/PBSA studies strongly suggested that compounds, beta-spinasterol, and asarinin form stable complexes with Mpro. The most significant hot spot residues such as Thr-25, Met-49, Cys-145, Met-165, and Gln-189 have strongly interacted with the selected chemical compounds. Our calculations suggest that asarinin is the best inhibitor to the Mpro, which supports these candidates and could be potent antiviral agent against SARS-CoV-2.

Automated summary

This study identified several compounds as potential drug targets for inhibiting SARS-CoV-2-related diseases, and these compounds exhibited potential drug-like properties and stability. Among them, asarinin was found to be the most effective inhibitor and may serve as a potent antiviral agent.